
Medicare GLP-1 Bridge: How the $50 Copay Works in 2026
Yes, Medicare now helps pay for weight-loss GLP-1s. Since July 1, 2026, the Medicare GLP-1 Bridge lets eligible people with Part D drug coverage get Wegovy, Zepbound KwikPen or Foundayo for a flat $50 a month, and CMS has extended it through December 31, 2027. If you are on Medicare, or you help a parent who is, open enrollment (Oct 15 to Dec 7, 2026) is the moment to make sure the drug coverage needed to use it stays in place.
Key facts
- $50 per month, flat (since July 1, 2026): that is the copay for a one-month supply, per CMS. The Part D deductible does not apply.
- Runs through Dec 31, 2027: CMS extended the Bridge because its longer-term BALANCE model will not launch in Part D in 2027.
- Three drugs covered (as of Aug 2026): Wegovy (shot and pill), Zepbound in the KwikPen form only, and Foundayo (orforglipron), per NCOA.
- Who qualifies: a BMI of 35 or higher, or 30+ with heart failure, uncontrolled high blood pressure or kidney disease, or 27+ with a past stroke, past heart attack, prediabetes or peripheral artery disease, per NCOA.
- About 3.8 million people: KFF’s estimate of Part D enrollees who are Bridge-eligible after exclusions, as reported by AJMC (July 2026).
- Open enrollment for 2027 plans: Oct 15 to Dec 7, 2026. You need a Part D plan or a Medicare Advantage plan with drug coverage to use the Bridge.
What is the Medicare GLP-1 Bridge?
It is a temporary CMS demonstration, basically a test program, that covers certain GLP-1 medicines for weight management outside the normal Part D benefit. Regular Part D covers GLP-1s for uses like type 2 diabetes or sleep apnea, but weight management on its own is the gap the Bridge fills. CMS Administrator Dr. Mehmet Oz put it this way at launch: “For too long, many Americans have been unable to access these treatments because of cost.”
How it runs in practice: a single central processor (Humana, under contract with CMS) handles prior authorization, claims and pharmacy payment. Your Part D plan does not have to opt in for you to use it. CMS says manufacturers agreed to a net price of about $245 per monthly supply, and you pay the $50 copay on top of Medicare’s share.
Which drugs are covered?
As of NCOA’s August 2026 guide, three:
- Wegovy (semaglutide), in both the weekly injection and the daily pill.
- Zepbound (tirzepatide), but only the KwikPen version.
- Foundayo (orforglipron), Lilly’s daily GLP-1 pill.
Ozempic and Mounjaro, the diabetes-branded versions, are not part of the Bridge. CMS has said the product list can change, so check Medicare.gov/glp1bridge for the current list. For how the two weekly shots differ, see semaglutide vs tirzepatide. For the two pills, see oral Wegovy vs Foundayo.
Who qualifies for the $50 copay?
You need to be enrolled in a standalone Part D plan or a Medicare Advantage plan that includes drug coverage. Then the medical criteria, per NCOA:
- BMI of 35 or higher, or
- BMI of 30 or higher plus heart failure, uncontrolled hypertension or kidney disease, or
- BMI of 27 or higher plus a previous stroke, previous heart attack, prediabetes or peripheral artery disease.
Nobody is enrolled automatically. A provider has to submit a prior authorization to the central processor, and NCOA says the request must confirm you received lifestyle counseling.
Who usually does not qualify: people who already get a GLP-1 through their regular Part D coverage, or who are eligible for it there. If the drug is prescribed for a Part D-covered use, such as type 2 diabetes, cardiovascular risk reduction, moderate to severe sleep apnea or MASH (a fatty liver disease), it goes through Part D instead, per the Obesity Action Coalition. That is not a loss: those people already have a coverage path.
The fine print
Good deal, real limits:
- The $50 does not count toward your yearly Part D out-of-pocket cap, per CMS. Extra Help, Medicare’s low-income subsidy, cannot lower it either.
- Manufacturer savings cards do not apply. The $50 is the price.
- No announced next step after 2027. CMS has not said what happens after Dec 31, 2027, as AJMC noted.
- Paperwork can slow things down. AJMC’s analysis suggested tighter documentation rules may limit how many eligible people actually get it.
- Side effects still apply. These are the same drugs with the same stomach side effects. NCOA also flags that rapid weight loss in older adults can mean muscle loss, and recommends enough protein, strength training and regular checkups.
What to check during open enrollment
Open enrollment runs Oct 15 to Dec 7, 2026, and changes take effect Jan 1, 2027, per Medicare.gov. The Bridge itself does not depend on which plan you pick, but it does depend on having drug coverage. The Obesity Action Coalition suggests checking:
- That you keep Part D or a Medicare Advantage plan with drug coverage in 2027.
- Whether your other medicines are on the plan’s 2027 formulary, plus prior authorization and step therapy rules.
- Whether your pharmacy stays in network.
- For Medicare Advantage, whether your doctors stay in network.
What it means for you
This is a real win on cost: a brand-name GLP-1 now costs eligible Medicare members a flat $50 a month. If you or a parent might qualify, the next step is a licensed provider who can check the BMI and health criteria, document them, and submit the prior authorization. Medicare.gov/glp1bridge and 1-800-MEDICARE can confirm eligibility. Not on Medicare? Our GLP-1 telehealth cost guide covers the other payment paths, and how to get peptides prescribed explains the legit route for everything else. For where unapproved peptides stand, see our legal status tracker.
Sources
- CMS: CMS launches Medicare GLP-1 Bridge, expanding access to GLP-1 medications (July 1, 2026)
- CMS: Medicare GLP-1 Bridge program page (updated July 13, 2026)
- NCOA: Medicare GLP-1 Bridge Program, eligibility, costs and how to get GLP-1 medications (Aug 18, 2026)
- AJMC: Medicare GLP-1 Bridge launches, but who actually qualifies? (July 6, 2026)
- Obesity Action Coalition: Medicare open enrollment, this is the year to check your coverage (Oct 12, 2026)
- Medicare.gov: Joining a plan, open enrollment dates
Educational content only, not medical advice, and not a guarantee of coverage. Program rules can change; confirm current eligibility at Medicare.gov or with a licensed provider.